Cargando…

The dosage of Patz1 modulates reprogramming process

The acquisition of pluripotent cells can be achieved by combined overexpression of transcription factors Oct4, Klf4, Sox2 and c-Myc in somatic cells. This cellular reprogramming process overcomes various barriers to re-activate pluripotency genes and re-acquire the highly dynamic pluripotent chromat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hui, Ow, Jin Rong, Tan, Bobby Cheng Peow, Goh, Ziyi, Feng, Bo, Loh, Yuin Han, Fedele, Monica, Li, Hu, Wu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268633/ https://www.ncbi.nlm.nih.gov/pubmed/25515777 http://dx.doi.org/10.1038/srep07519

Ejemplares similares

The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation
por: Mancinelli, Sara, et al.
Publicado: (2021)

The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement
por: Fedele, Monica, et al.
Publicado: (2017)

PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas
por: Passariello, Annalisa, et al.
Publicado: (2019)

Structural analysis of the PATZ1 BTB domain homodimer
por: Piepoli, Sofia, et al.
Publicado: (2020)

PATZ1 Induces Apoptosis through PUMA in Glioblastoma
por: Tao, Xiang, et al.
Publicado: (2022)

PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells
por: Vitiello, Michela, et al.
Publicado: (2016)

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype
por: Guadagno, Elia, et al.
Publicado: (2017)

Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene
por: Monaco, Mario, et al.
Publicado: (2018)

PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas
por: Franco, Renato, et al.
Publicado: (2016)

PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context
por: Valentino, T, et al.
Publicado: (2013)

Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene
por: Vitiello, Michela, et al.
Publicado: (2019)

Zfp322a Regulates Mouse ES Cell Pluripotency and Enhances Reprogramming Efficiency
por: Ma, Hui, et al.
Publicado: (2014)

PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration
por: Chiappetta, Gennaro, et al.
Publicado: (2015)

PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype
por: Lucà, Stefano, et al.
Publicado: (2023)

PATZ1 knockdown enhances malignant phenotype in thyroid epithelial follicular cells and thyroid cancer cells
por: Iesato, Asumi, et al.
Publicado: (2017)

Expanding the spectrum of EWSR1‐PATZ1 rearranged CNS tumors: An infantile case with leptomeningeal dissemination
por: Rossi, Sabrina, et al.
Publicado: (2021)

The association between PaTz and improved palliative care in the primary care setting: a cross-sectional survey
por: Koper, Ian, et al.
Publicado: (2019)

PATZ1 down-regulates FADS1 by binding to rs174557 and is opposed by SP1/SREBP1c
por: Pan, Gang, et al.
Publicado: (2017)

Variation in the implementation of PaTz: a method to improve palliative care in general practice - a prospective observational study
por: Koper, Ian, et al.
Publicado: (2020)

PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
por: Alhalabi, Karam T., et al.
Publicado: (2021)

Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen
por: Goh, Corinna Jie Hui, et al.
Publicado: (2021)

Correction to: Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen
por: Goh, Corinna Jie Hui, et al.
Publicado: (2022)

PATZ1 (MAZR) Co-occupies Genomic Sites With p53 and Inhibits Liver Cancer Cell Proliferation via Regulating p27
por: Ng, Zhen Long, et al.
Publicado: (2021)

Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors
por: Cheng, Hui, et al.
Publicado: (2016)

POZ/BTB and AT-Hook-Containing Zinc Finger Protein 1 (PATZ1) Suppresses Progression of Ovarian Cancer and Serves as an Independent Prognosis Factor
por: Zhao, Cuihong, et al.
Publicado: (2018)

Strengthening the spiritual domain in palliative care through a listening consultation service by spiritual caregivers in Dutch PaTz-groups: an evaluation study
por: Klop, Hanna T., et al.
Publicado: (2020)

A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

PATZ1 induces PP4R2 to form a negative feedback loop on IKK/NF-κB signaling in lung cancer
por: Ho, Ming-Yi, et al.
Publicado: (2016)

Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights
por: Ene, Andre, et al.
Publicado: (2023)

X Chromosome Dosage Influences DNA Methylation Dynamics during Reprogramming to Mouse iPSCs
por: Pasque, Vincent, et al.
Publicado: (2018)

Dynamics of DNA Methylation Reprogramming Influenced by X Chromosome Dosage in Induced Pluripotent Stem Cells
por: Janiszewski, Adrian, et al.
Publicado: (2018)

Novel live cell fluorescent probe for human-induced pluripotent stem cells highlights early reprogramming population
por: Sriram, Sandhya, et al.
Publicado: (2021)

Editorial: Metabolic reprogramming and cancer progression
por: Yin, Qinan, et al.
Publicado: (2022)

Perk Gene Dosage Regulates Glucose Homeostasis by Modulating Pancreatic β-Cell Functions
por: Wang, Rong, et al.
Publicado: (2014)

Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype
por: Hiew, Michele Sook Yuin, et al.
Publicado: (2018)

Aberrant DNA methylation reprogramming in bovine SCNT preimplantation embryos
por: Zhang, Sheng, et al.
Publicado: (2016)

Dosage
por: Servoss, George L.
Publicado: (1911)

Extraneous E-Cadherin Engages the Deterministic Process of Somatic Reprogramming through Modulating STAT3 and Erk1/2 Activity
por: Liu, Yu-Hao, et al.
Publicado: (2021)

PaTz groups for primary palliative care: reinventing cooperation between general practitioners and district nurses in palliative care: an evaluation study combining data from focus groups and a questionnaire
por: van der Plas, Annicka GM, et al.
Publicado: (2014)

Chromatin modifying enzymes as modulators of reprogramming
por: Onder, Tamer T., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k73uf9a53l7uau4huko3c1vfde